| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 3.40e-05 | 2 | 117 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 3.40e-05 | 2 | 117 | 2 | GO:0103002 | |
| HumanPheno | Diarrhea | MYD88 CDKN2C RAG1 MAP3K14 HMGCL DPM1 NOD2 CD3D PIGT SLC12A3 CLPB CARD11 PLEC PINK1 | 1.50e-05 | 431 | 46 | 14 | HP:0002014 |
| MousePheno | abnormal renal sodium ion transport | 1.77e-05 | 8 | 97 | 3 | MP:0011442 | |
| Domain | Liprin | 1.96e-08 | 6 | 114 | 4 | IPR029515 | |
| Domain | SAM_1 | 5.95e-05 | 68 | 114 | 5 | PF00536 | |
| Domain | SAM_2 | 1.35e-04 | 43 | 114 | 4 | PF07647 | |
| Domain | C2 | 1.52e-04 | 131 | 114 | 6 | PF00168 | |
| Domain | C2 | 1.95e-04 | 137 | 114 | 6 | SM00239 | |
| Domain | SAM | 2.03e-04 | 88 | 114 | 5 | SM00454 | |
| Domain | Junctophilin | 2.20e-04 | 4 | 114 | 2 | IPR017191 | |
| Domain | C2 | 2.36e-04 | 142 | 114 | 6 | PS50004 | |
| Domain | SAM_DOMAIN | 2.90e-04 | 95 | 114 | 5 | PS50105 | |
| Domain | - | 2.95e-04 | 148 | 114 | 6 | 2.60.40.150 | |
| Domain | SAM | 3.20e-04 | 97 | 114 | 5 | IPR001660 | |
| Domain | - | 4.81e-04 | 106 | 114 | 5 | 1.10.150.50 | |
| Domain | Kinase-like_dom | MAP3K14 WDR81 ACVR2B MAST2 BLK PIK3C2B DSTYK MAP3K11 PRKCH ROS1 PINK1 | 4.82e-04 | 542 | 114 | 11 | IPR011009 |
| Domain | C2_dom | 5.11e-04 | 164 | 114 | 6 | IPR000008 | |
| Domain | SAM/pointed | 7.55e-04 | 117 | 114 | 5 | IPR013761 | |
| Domain | BEACH | 1.29e-03 | 9 | 114 | 2 | PS50197 | |
| Domain | Beach | 1.29e-03 | 9 | 114 | 2 | PF02138 | |
| Domain | - | 1.29e-03 | 9 | 114 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.29e-03 | 9 | 114 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.29e-03 | 9 | 114 | 2 | IPR000409 | |
| Domain | PROTEIN_KINASE_ATP | 2.01e-03 | 459 | 114 | 9 | PS00107 | |
| Domain | SH3 | 2.11e-03 | 216 | 114 | 6 | SM00326 | |
| Domain | SH3 | 2.11e-03 | 216 | 114 | 6 | PS50002 | |
| Domain | PDZ | 2.15e-03 | 148 | 114 | 5 | SM00228 | |
| Domain | Cys-rich_flank_reg_C | 2.25e-03 | 90 | 114 | 4 | IPR000483 | |
| Domain | LRRCT | 2.25e-03 | 90 | 114 | 4 | SM00082 | |
| Domain | - | 2.27e-03 | 150 | 114 | 5 | 2.30.42.10 | |
| Domain | SH3_domain | 2.31e-03 | 220 | 114 | 6 | IPR001452 | |
| Domain | PDZ | 2.34e-03 | 151 | 114 | 5 | PS50106 | |
| Domain | PDZ | 2.41e-03 | 152 | 114 | 5 | IPR001478 | |
| Domain | - | 2.53e-03 | 93 | 114 | 4 | 1.10.533.10 | |
| Domain | Prot_kinase_dom | 3.07e-03 | 489 | 114 | 9 | IPR000719 | |
| Domain | DEATH-like_dom | 3.17e-03 | 99 | 114 | 4 | IPR011029 | |
| Domain | MORN | 3.20e-03 | 14 | 114 | 2 | SM00698 | |
| Domain | PROTEIN_KINASE_DOM | 3.24e-03 | 493 | 114 | 9 | PS50011 | |
| Domain | MORN | 3.68e-03 | 15 | 114 | 2 | IPR003409 | |
| Domain | MORN | 3.68e-03 | 15 | 114 | 2 | PF02493 | |
| Domain | LRRNT | 4.16e-03 | 53 | 114 | 3 | PF01462 | |
| Domain | PlsC | 4.73e-03 | 17 | 114 | 2 | SM00563 | |
| Domain | Plipid/glycerol_acylTrfase | 4.73e-03 | 17 | 114 | 2 | IPR002123 | |
| Domain | CYTOCHROME_P450 | 5.10e-03 | 57 | 114 | 3 | PS00086 | |
| Domain | - | 5.35e-03 | 58 | 114 | 3 | 1.10.630.10 | |
| Domain | p450 | 5.35e-03 | 58 | 114 | 3 | PF00067 | |
| Domain | Cyt_P450 | 5.89e-03 | 60 | 114 | 3 | IPR001128 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.08e-07 | 20 | 86 | 5 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 1.08e-07 | 20 | 86 | 5 | MM14991 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.89e-06 | 17 | 86 | 4 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 2.89e-06 | 17 | 86 | 4 | MM14907 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.20e-06 | 67 | 86 | 6 | MM15327 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.70e-06 | 18 | 86 | 4 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.70e-06 | 18 | 86 | 4 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.70e-06 | 18 | 86 | 4 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.70e-06 | 18 | 86 | 4 | M27043 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.05e-05 | 23 | 86 | 4 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.05e-05 | 23 | 86 | 4 | M12627 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.25e-05 | 24 | 86 | 4 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.25e-05 | 24 | 86 | 4 | M630 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.47e-05 | 87 | 86 | 6 | M27617 | |
| Pathway | REACTOME_EICOSANOIDS | 4.63e-05 | 12 | 86 | 3 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 4.63e-05 | 12 | 86 | 3 | MM14845 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.59e-04 | 51 | 86 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.59e-04 | 51 | 86 | 4 | MM14499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION | 7.57e-04 | 7 | 86 | 2 | M47633 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 8.71e-04 | 31 | 86 | 3 | M39851 | |
| Pubmed | 6.50e-10 | 5 | 119 | 4 | 19013515 | ||
| Pubmed | Analyses of the spatiotemporal expression and subcellular localization of liprin-α proteins. | 1.94e-09 | 6 | 119 | 4 | 21618221 | |
| Pubmed | 1.62e-08 | 9 | 119 | 4 | 12923177 | ||
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 6.31e-08 | 12 | 119 | 4 | 9624153 | |
| Pubmed | 6.82e-08 | 31 | 119 | 5 | 15217342 | ||
| Pubmed | 3.89e-07 | 5 | 119 | 3 | 28580440 | ||
| Pubmed | Autophagy controls mucus secretion from intestinal goblet cells by alleviating ER stress. | 3.89e-07 | 5 | 119 | 3 | 36738733 | |
| Pubmed | A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity. | 1.10e-06 | 23 | 119 | 4 | 22761313 | |
| Pubmed | Interaction between GRIP and liprin-alpha/SYD2 is required for AMPA receptor targeting. | 1.35e-06 | 7 | 119 | 3 | 11931740 | |
| Pubmed | SHANK1 DCHS2 PDHB LONRF1 UBR4 METTL26 DPM1 STAB1 RNF123 THOP1 MAP1S CLPB PKD1 MAP3K11 PLEC PINK1 JPH3 | 1.87e-06 | 1285 | 119 | 17 | 35914814 | |
| Pubmed | Interaction between liprin-alpha and GIT1 is required for AMPA receptor targeting. | 3.23e-06 | 9 | 119 | 3 | 12629171 | |
| Pubmed | BCG vaccination-induced emergency granulopoiesis provides rapid protection from neonatal sepsis. | 3.23e-06 | 9 | 119 | 3 | 32376769 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 3.33e-06 | 30 | 119 | 4 | 16186258 | |
| Pubmed | Sex-hormone-driven innate antibodies protect females and infants against EPEC infection. | 4.61e-06 | 10 | 119 | 3 | 30250184 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDOR1 LONRF1 UBR4 MAST2 PLXNB2 TIAM2 NOD2 MAP1S PIK3C2B NBEAL2 PKD1 NAV1 MAP3K11 PLEC CRAMP1 | 5.85e-06 | 1105 | 119 | 15 | 35748872 |
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 6.32e-06 | 11 | 119 | 3 | 34767769 | |
| Pubmed | 8.40e-06 | 12 | 119 | 3 | 21622562 | ||
| Pubmed | ENU-mutagenesis: insight into immune function and pathology. | 1.09e-05 | 13 | 119 | 3 | 16889948 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15611369 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 29440372 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 1.16e-05 | 2 | 119 | 2 | 23641057 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 28912346 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24413902 | ||
| Pubmed | MAP1S Protein Regulates the Phagocytosis of Bacteria and Toll-like Receptor (TLR) Signaling. | 1.16e-05 | 2 | 119 | 2 | 26565030 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 8031839 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 10860550 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 24133169 | ||
| Pubmed | Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension. | 1.16e-05 | 2 | 119 | 2 | 11320253 | |
| Pubmed | Characterization of the CYP4A11 gene, a second CYP4A gene in humans. | 1.16e-05 | 2 | 119 | 2 | 12464262 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 34031393 | ||
| Pubmed | Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta. | 1.16e-05 | 2 | 119 | 2 | 15066132 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 23825080 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16691295 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 3829886 | ||
| Pubmed | Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice. | 1.16e-05 | 2 | 119 | 2 | 29277328 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 16809425 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 21820496 | ||
| Pubmed | Renal function and vasomotor activity in mice lacking the Cyp4a14 gene. | 1.16e-05 | 2 | 119 | 2 | 20943934 | |
| Pubmed | Lymphocyte-derived ACh regulates local innate but not adaptive immunity. | 1.16e-05 | 2 | 119 | 2 | 23297238 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 2766933 | ||
| Pubmed | NOD2 deficiency results in increased susceptibility to peptidoglycan-induced uveitis in mice. | 1.16e-05 | 2 | 119 | 2 | 21296813 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 27647833 | ||
| Pubmed | Inducible MHC class II expression by mast cells supports effector and regulatory T cell activation. | 1.16e-05 | 2 | 119 | 2 | 19342644 | |
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 15845450 | ||
| Pubmed | 1.16e-05 | 2 | 119 | 2 | 17112342 | ||
| Pubmed | T cell-mediated regulation of the microbiota protects against obesity. | 1.16e-05 | 2 | 119 | 2 | 31346040 | |
| Pubmed | High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE. | 1.16e-05 | 2 | 119 | 2 | 30088983 | |
| Pubmed | Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. | 1.16e-05 | 2 | 119 | 2 | 19208908 | |
| Pubmed | 1.86e-05 | 329 | 119 | 8 | 17474147 | ||
| Pubmed | 2.12e-05 | 16 | 119 | 3 | 23630357 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | SART3 MYD88 CAND2 PDHB POLR2B UBR4 DPM1 MAP1S MRPL22 MRPL9 DDX39B | 3.15e-05 | 704 | 119 | 11 | 29955894 |
| Pubmed | Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice. | 3.47e-05 | 3 | 119 | 2 | 2354437 | |
| Pubmed | Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects. | 3.47e-05 | 3 | 119 | 2 | 26926994 | |
| Pubmed | Liprin-α3 controls vesicle docking and exocytosis at the active zone of hippocampal synapses. | 3.47e-05 | 3 | 119 | 2 | 29439199 | |
| Pubmed | Variable SATB1 Levels Regulate Hematopoietic Stem Cell Heterogeneity with Distinct Lineage Fate. | 3.47e-05 | 3 | 119 | 2 | 29898394 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 25722298 | ||
| Pubmed | Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy. | 3.47e-05 | 3 | 119 | 2 | 36351375 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19075245 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 22851749 | ||
| Pubmed | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 3.47e-05 | 3 | 119 | 2 | 28270609 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 25088769 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 37659685 | ||
| Pubmed | Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. | 3.47e-05 | 3 | 119 | 2 | 27879260 | |
| Pubmed | MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma. | 3.47e-05 | 3 | 119 | 2 | 27915469 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 9271096 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 38861331 | ||
| Pubmed | Nod2 is required for the regulation of commensal microbiota in the intestine. | 3.47e-05 | 3 | 119 | 2 | 19805227 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 22323829 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 29734251 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 25125146 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 8011168 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 14559359 | ||
| Pubmed | Absence of innate MyD88 signaling promotes inducible allograft acceptance. | 3.47e-05 | 3 | 119 | 2 | 17015716 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 21233312 | ||
| Pubmed | The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. | 3.47e-05 | 3 | 119 | 2 | 1991046 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 15615857 | ||
| Pubmed | Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins. | 3.47e-05 | 3 | 119 | 2 | 17904530 | |
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19713718 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 15313227 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 19570976 | ||
| Pubmed | 3.47e-05 | 3 | 119 | 2 | 20498021 | ||
| Pubmed | Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma. | 3.47e-05 | 3 | 119 | 2 | 22808296 | |
| Pubmed | Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling. | 3.47e-05 | 3 | 119 | 2 | 28576260 | |
| Pubmed | Identification of Natural Regulatory T Cell Epitopes Reveals Convergence on a Dominant Autoantigen. | 3.47e-05 | 3 | 119 | 2 | 28709804 | |
| Pubmed | SHANK1 SART3 PDHB PPFIA2 UBR4 HMGCL MCCC2 PPFIA3 MAP1S SLITRK5 NAV1 PLEC DDX39B JPH3 | 3.65e-05 | 1139 | 119 | 14 | 36417873 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 3.74e-05 | 363 | 119 | 8 | 14691545 | |
| Pubmed | 4.27e-05 | 20 | 119 | 3 | 23791195 | ||
| Pubmed | The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. | 6.93e-05 | 4 | 119 | 2 | 21512004 | |
| Pubmed | Homeostatic control of memory cell progenitors in the natural killer cell lineage. | 6.93e-05 | 4 | 119 | 2 | 25578733 | |
| Pubmed | IL-18-induced HIF-1α in ILC3s ameliorates the inflammation of C. rodentium-induced colitis. | 6.93e-05 | 4 | 119 | 2 | 38019650 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 32610078 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 31201384 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 8334987 | ||
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 23341605 | ||
| Pubmed | Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. | 6.93e-05 | 4 | 119 | 2 | 17705131 | |
| Pubmed | Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity. | 6.93e-05 | 4 | 119 | 2 | 26371185 | |
| Pubmed | Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production. | 6.93e-05 | 4 | 119 | 2 | 20029045 | |
| Pubmed | Paneth cells secrete lysozyme via secretory autophagy during bacterial infection of the intestine. | 6.93e-05 | 4 | 119 | 2 | 28751470 | |
| Pubmed | 6.93e-05 | 4 | 119 | 2 | 23027925 | ||
| Pubmed | Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. | 6.93e-05 | 4 | 119 | 2 | 17347645 | |
| Cytoband | 16p13.3 | 4.46e-05 | 244 | 119 | 6 | 16p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 4.17e-04 | 681 | 119 | 8 | chr1p36 | |
| Cytoband | 3p22 | 5.10e-04 | 13 | 119 | 2 | 3p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p13 | 8.85e-04 | 426 | 119 | 6 | chr16p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 9.87e-04 | 290 | 119 | 5 | chr1q32 | |
| Cytoband | 1q32.1 | 2.84e-03 | 108 | 119 | 3 | 1q32.1 | |
| Cytoband | 20q13.13 | 3.14e-03 | 32 | 119 | 2 | 20q13.13 | |
| Cytoband | 5p15.33 | 3.14e-03 | 32 | 119 | 2 | 5p15.33 | |
| Cytoband | 1p33 | 3.75e-03 | 35 | 119 | 2 | 1p33 | |
| GeneFamily | Sterile alpha motif domain containing | 5.25e-05 | 88 | 83 | 5 | 760 | |
| GeneFamily | PDZ domain containing | 6.74e-04 | 152 | 83 | 5 | 1220 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 7.34e-04 | 9 | 83 | 2 | 1230 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 5.44e-06 | 210 | 119 | 8 | M1303 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_UP | 6.04e-06 | 213 | 119 | 8 | MM1125 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.10e-06 | 199 | 119 | 7 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 4.93e-06 | 162 | 119 | 6 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-06 | 169 | 119 | 6 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 6d5bdfbe53608e01c3845ecd908ca6d0fecc58f8 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 6839ee3bb4457d13cb08ca8eb79ae33ddd256783 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.66e-06 | 175 | 119 | 6 | 9d6135e183179968555670abec39dff9da2c3219 | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.26e-05 | 191 | 119 | 6 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.34e-05 | 193 | 119 | 6 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | COPD-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.34e-05 | 193 | 119 | 6 | 0020249fa71afb500af73700543bb6f349be6b10 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 193 | 119 | 6 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 194 | 119 | 6 | 74a9fdb73f279bebb6337510deab9aaaf9f7e957 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 197 | 119 | 6 | 2a140c61e81aa18de2c9c1c443e314d6f09cdc18 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 197 | 119 | 6 | fa3fe934bd5fd8c6520a9c46357f9e441c794aba | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-05 | 197 | 119 | 6 | 32eb4437cc608b8369e376446d639497ecfdd17a | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 2.25e-05 | 126 | 119 | 5 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.87e-05 | 154 | 119 | 5 | c663e9834be0b45389a862dc3c13a1f988a3e5ee | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-05 | 160 | 119 | 5 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.25e-05 | 161 | 119 | 5 | 2849fbc9611af208241b33da3cd18290aafe426b | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 161 | 119 | 5 | 7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 165 | 119 | 5 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 165 | 119 | 5 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-05 | 167 | 119 | 5 | 3c3e1c31aacca48099693aea2efdfa22fc0e4af4 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Zbtb32+_B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.61e-05 | 167 | 119 | 5 | 77a4d7ce44847c76074d4f5340d61b398fe43e6c | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 9.11e-05 | 169 | 119 | 5 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-05 | 88 | 119 | 4 | 142d2e00ef19c0ad011a21945bf1111271056eae | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.37e-05 | 170 | 119 | 5 | f664c7559e383b37845c123e41a3be316d869ba0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.37e-05 | 170 | 119 | 5 | 0272eb1487c2545d4aa06f5d1cd77f823e1441e9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.90e-05 | 172 | 119 | 5 | b84610f1e5889a655652800c2b3270d264bfe1a9 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 174 | 119 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-04 | 174 | 119 | 5 | ab654e87c7eab7f33adc61be7a86da5c4d88008d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 174 | 119 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | BAL-Control-Myeloid-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-04 | 174 | 119 | 5 | d9bccff5258c4277bdd1edbd87e17c327ec125e8 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-04 | 174 | 119 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | BAL-Control-Myeloid-pDC-pDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-04 | 174 | 119 | 5 | 2453419842fd22d066631615403393bfe4449bb8 | |
| ToppCell | CF-Lymphoid-pDC|CF / Disease state, Lineage and Cell class | 1.10e-04 | 176 | 119 | 5 | dd1e529a9e413bcaab43584afbe059e1464ffb53 | |
| ToppCell | NS-moderate-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 177 | 119 | 5 | de1ffe3df76100d46ca158bdd2fea2ebbd4656b4 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 177 | 119 | 5 | 3743a7d69db9ac4cad70eb531f7075849f34f16b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-04 | 179 | 119 | 5 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | COPD-Myeloid-pDC|Myeloid / Disease state, Lineage and Cell class | 1.19e-04 | 179 | 119 | 5 | 29b058c5e33fda9f0d738c074bdb67ff16b9b6d5 | |
| ToppCell | moderate-Myeloid-pDC|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.22e-04 | 180 | 119 | 5 | a0751ad5e42a21cb107d900abfa9ee967a0069fc | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-04 | 180 | 119 | 5 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-04 | 182 | 119 | 5 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 184 | 119 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.39e-04 | 185 | 119 | 5 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.43e-04 | 186 | 119 | 5 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | tumor_Lung-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 1.43e-04 | 186 | 119 | 5 | 3d7c1a281fb82db4471283f39937007d889a5f38 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-04 | 186 | 119 | 5 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.43e-04 | 186 | 119 | 5 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.43e-04 | 186 | 119 | 5 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.43e-04 | 186 | 119 | 5 | 79aedd5aed72509a4925e9f6cb43bc0c798c86f5 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.46e-04 | 187 | 119 | 5 | 9d298f43ae81d72091b31aaa6df41046d4aa31c5 | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 1.50e-04 | 188 | 119 | 5 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 189 | 119 | 5 | a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd | |
| ToppCell | PCW_13-14-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC3_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 189 | 119 | 5 | 78dcda09109a5cfb04ba069f16ec80987b3ad432 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 189 | 119 | 5 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | Control-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.58e-04 | 190 | 119 | 5 | 1584c68b58c7f406d9b0e8451beea3e6f8980c56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 119 | 5 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | (3)_MNP-(3)_DC_activated|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.62e-04 | 191 | 119 | 5 | 0353bf797c4ef237b9bb82460c173c7d03cb8883 | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 119 | 5 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-04 | 193 | 119 | 5 | 1db487e5f81849740d57cc3e2b5739e8f7581efb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 193 | 119 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 194 | 119 | 5 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 194 | 119 | 5 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | b490fffc94f005dff9a34ce34d80ca776e3a1387 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 1.74e-04 | 194 | 119 | 5 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 1.74e-04 | 194 | 119 | 5 | 5c58a2d1dd3c8ff77ce44d473239685e6b020909 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | b0c15e7e4bcf30856fb628dedd7ba82df33489f5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 194 | 119 | 5 | fa6d51f36a3dae8763a595c20892987ed454c0f0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-04 | 194 | 119 | 5 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.78e-04 | 195 | 119 | 5 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 195 | 119 | 5 | 3365768101454060b9ea96ef6b426c76c150bc8f | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.78e-04 | 195 | 119 | 5 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 1.82e-04 | 196 | 119 | 5 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 196 | 119 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 196 | 119 | 5 | 22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-04 | 196 | 119 | 5 | b10b386aacc672949560df2dbb0d4f76cf62e213 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 196 | 119 | 5 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.82e-04 | 196 | 119 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | mild_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.86e-04 | 197 | 119 | 5 | 368644260f70895052a1d71171a9d882315354dd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.86e-04 | 197 | 119 | 5 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-04 | 197 | 119 | 5 | 311438418f3d697e54222da111014c887fd815f5 | |
| ToppCell | myeloid-Monocyte|myeloid / Lineage, cell class and subclass | 1.86e-04 | 197 | 119 | 5 | 6acf059cee6ba6bdeacc089b090d72336790972a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 1.91e-04 | 198 | 119 | 5 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.91e-04 | 198 | 119 | 5 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 1.91e-04 | 198 | 119 | 5 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | severe_influenza-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 1.91e-04 | 198 | 119 | 5 | 790ee20abc9666b8095675b0d445c0914ee70ea3 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 198 | 119 | 5 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|Healthy_donor / disease group, cell group and cell class (v2) | 1.91e-04 | 198 | 119 | 5 | d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|Healthy/Control / Disease group and Cell class | 1.91e-04 | 198 | 119 | 5 | 0badaf1fa5328d06291c3624d0f63196ffc81527 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 1.95e-04 | 199 | 119 | 5 | 6795ff31f92580195c9db776951f99d647484d24 | |
| Disease | X-14939 measurement | 2.27e-04 | 6 | 116 | 2 | EFO_0800747 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 2.96e-04 | 33 | 116 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | 10-undecenoate 11:1n1 measurement | 3.18e-04 | 7 | 116 | 2 | EFO_0021099 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 8.23e-04 | 11 | 116 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | diffuse large B-cell lymphoma (is_implicated_in) | 9.86e-04 | 12 | 116 | 2 | DOID:0050745 (is_implicated_in) | |
| Disease | waist-hip ratio | CAND2 TFAP2D ESR2 MAP3K14 PTGIS CDKAL1 STAB1 LACTBL1 RNF123 PIK3C2B DSTYK PKD1 HSD11B2 | 1.08e-03 | 1226 | 116 | 13 | EFO_0004343 |
| Disease | Diffuse Large B-Cell Lymphoma | 1.34e-03 | 55 | 116 | 3 | C0079744 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 1.35e-03 | 14 | 116 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | severe combined immunodeficiency (is_implicated_in) | 1.35e-03 | 14 | 116 | 2 | DOID:627 (is_implicated_in) | |
| Disease | hypertension (is_implicated_in) | 1.35e-03 | 121 | 116 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 1.63e-03 | 215 | 116 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.89e-03 | 62 | 116 | 3 | DOID:9074 (is_implicated_in) | |
| Disease | creatinine measurement | CAND2 MYH7B PPFIA2 MAP3K14 ACVR2B MAST2 PLXNB2 BLK RNF123 MAP3K11 PLEC | 1.90e-03 | 995 | 116 | 11 | EFO_0004518 |
| Disease | response to radiation, Urinary retention | 2.00e-03 | 17 | 116 | 2 | GO_0009314, HP_0000016 | |
| Disease | essential hypertension (is_implicated_in) | 2.25e-03 | 18 | 116 | 2 | DOID:10825 (is_implicated_in) | |
| Disease | Disorder of organic acid metabolism | 2.25e-03 | 18 | 116 | 2 | cv:C1263739 | |
| Disease | Omenn Syndrome | 2.51e-03 | 19 | 116 | 2 | C2700553 | |
| Disease | red blood cell density measurement | 2.51e-03 | 880 | 116 | 10 | EFO_0007978 | |
| Disease | prostate carcinoma | CDKN2C COL6A3 ESR2 ODAD2 MAST2 DPM1 CDKAL1 PIK3C2B PRKCH CRAMP1 | 2.75e-03 | 891 | 116 | 10 | EFO_0001663 |
| Disease | Severe Combined Immunodeficiency | 2.78e-03 | 20 | 116 | 2 | C0085110 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.79e-03 | 71 | 116 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | asthma | 2.90e-03 | 751 | 116 | 9 | MONDO_0004979 | |
| Disease | serum non-albumin protein measurement | 3.09e-03 | 361 | 116 | 6 | EFO_0004568 | |
| Disease | brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement | 3.36e-03 | 22 | 116 | 2 | EFO_0004277, EFO_0006790, EFO_0006792, EFO_0006797, EFO_0006798 | |
| Disease | vital capacity | COL6A3 CAND2 MYH7B DOK7 POLR2B MAP3K14 ODAD2 TIAM2 PRDM11 MTMR11 PIK3C2B TSGA10IP | 3.46e-03 | 1236 | 116 | 12 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIGSLRLADLLRADP | 156 | A6NGE7 | |
| RPLGSHRRKELGKVL | 846 | A0FGR9 | |
| AGGPLGRRLSFLLRK | 406 | Q8NFU1 | |
| TRLDLGKRILDPRGI | 56 | P04234 | |
| LPLGIARSRGHVKLA | 1146 | Q9Y6Y1 | |
| LGHLDLSGNRLRKLP | 166 | P02750 | |
| LSGNRLRKLPPGLLA | 171 | P02750 | |
| ARLRGHLPGALAEKR | 176 | Q7RTU5 | |
| GTPGRILALARNKSL | 171 | Q13838 | |
| LLRRGKRHLQGDGLS | 151 | Q9UKB5 | |
| LKSKNGIHLRLRRLP | 496 | Q02928 | |
| FPGLLGLRVLRLSHN | 286 | P35858 | |
| GFQGRLRKSLPSLLR | 306 | P21730 | |
| KGLLPLLRSSRGRIV | 201 | P80365 | |
| KASLIKLRALRRPGG | 631 | A6NI56 | |
| RILLRPREKKLGLGT | 86 | O60762 | |
| REKLDRLGLNLPAGR | 266 | Q7Z6R9 | |
| KGGRPRQHLLSLTRR | 391 | P15918 | |
| KRLGTGTLRSLRPIL | 46 | Q7Z3E1 | |
| LLKDFPLRRVSRLHG | 26 | Q8TAE7 | |
| QGPGKLKLIIRRDHL | 1211 | Q9P2P5 | |
| LKIGLSLAPRRGSLP | 476 | Q6P3S6 | |
| GLVRRPLREVSGLLK | 6 | P11177 | |
| LLRSAIKALRPGGIL | 246 | Q9H649 | |
| LLEFARLVRGLGLKP | 331 | Q8NF37 | |
| DSLPGLNSLLRRKLA | 296 | Q66K74 | |
| KRSGGHAPRVRELLL | 246 | Q92731 | |
| ARALHISRGKLLPRE | 71 | Q9HCC0 | |
| GLSRVQLLRPGSLHK | 111 | A4FU01 | |
| GRSSKRQLFLLPGGL | 3206 | Q9UKN7 | |
| GLSPKESLLHLLIRR | 266 | Q86W26 | |
| REIGISNPLHRLKLR | 881 | O75145 | |
| RTLRLEKLGHPALSQ | 706 | O75335 | |
| LLRRGELLALGGHLK | 51 | Q17RB8 | |
| RLVHGGRVRSLLPLA | 336 | Q96JJ6 | |
| LKRPRRNGLGLISTI | 466 | Q96I76 | |
| SSGDLLKGLLHPRVR | 436 | A7E2Y1 | |
| LGLLGAGASLRPRKL | 11 | O15031 | |
| LQLGRALLLRFTGKP | 11 | Q9BXM7 | |
| PLVLGKARARRTLGH | 436 | P11678 | |
| RPGASVGRLLELLTK | 81 | Q99836 | |
| REIGISNPLHRLKLR | 921 | Q13136 | |
| LLHVLRLAGPGALRK | 201 | A6NHZ5 | |
| KVLGARHLPKLGRSI | 1066 | P16885 | |
| VLLHRKPKLGQELGR | 646 | Q6XUX3 | |
| KLHRRLLQLGGSALL | 111 | Q9UHB4 | |
| PAGRRTDLKLLRGLS | 71 | O00750 | |
| KLLLLPGRRDTPHGR | 21 | Q6V1P9 | |
| SLGGLDVRRRIPIKL | 16 | Q75N03 | |
| SGLHRLLFLRGTRIP | 21 | Q9BZ23 | |
| KLGNPEIARRLLLRG | 46 | P42773 | |
| AKLAVALLGGGPRRL | 261 | A8MY62 | |
| KAGLVLRRLSTLLVG | 86 | Q8N6M3 | |
| GRRLGGARLDLPKIR | 186 | Q5VV42 | |
| IPRQSLRLVRKLGSG | 236 | P51451 | |
| HLGLKGIRSALKRPV | 226 | P48165 | |
| LKSKNGIHLRLRRLP | 496 | Q5TCH4 | |
| AGQKRGALRLLVPRL | 11 | Q9H9V9 | |
| LRLRGGSPLNTGKAL | 1506 | P12111 | |
| RPGSLPTALHKQRLL | 716 | Q96RY5 | |
| SPALRALLRKLGGLF | 236 | Q6NUI2 | |
| LLGGLTAPTDRKRSL | 101 | Q8WW18 | |
| RKGLGLRPQTLLRVG | 91 | Q9NVV2 | |
| SLTAGLKELSLPRRG | 151 | Q6P0Q8 | |
| TKLHLSPPLGRQLSR | 1376 | Q6P0Q8 | |
| NLTLPRGIGEKLLLR | 571 | Q9NWL6 | |
| LLLRLLRSPTLRGHG | 16 | Q9H078 | |
| LEKRLSLLSHAGRPG | 241 | Q18PE1 | |
| LLPRLRKQLAAGRPH | 971 | O75155 | |
| RGKGRTQLSLLPRAL | 906 | Q15020 | |
| ILRRHGLLPSSLKRI | 391 | Q8N697 | |
| LPSKINRAGRLLDIL | 66 | Q9BXL7 | |
| RDLLSRTKKPGGLRI | 166 | B7ZC32 | |
| GTPKLIQRALLRGTA | 636 | Q16584 | |
| REIGISNPLHRLKLR | 941 | O75334 | |
| LSRTGLVEGLRKRLL | 3536 | P98161 | |
| GLRPALPRSELHKLI | 216 | Q99558 | |
| NLRSRGKLALGVLPQ | 16 | Q9NWU5 | |
| GIGRITKRLLLPLFR | 71 | Q9BV86 | |
| GLFRAAGHLLKPRAL | 121 | Q96S19 | |
| SLLLKHRRLVLSGPS | 1546 | Q8NEY1 | |
| VRLQAPGTRTGLLKL | 26 | Q3SY00 | |
| PLSLLLNLGRRSKIG | 431 | Q92581 | |
| LHRLLRKMLRGSGLP | 461 | A6NFQ2 | |
| LLTKAGAADAPLRLR | 356 | O75019 | |
| DRLLPKLARGSLSVG | 211 | Q16647 | |
| GTLNLSVLLPLGLRK | 16 | Q9Y2Z4 | |
| TRDLVRLHGGLKPLA | 706 | Q5T2S8 | |
| KALPRRLVGLASLRA | 6 | P35914 | |
| DGSLRVTALPRGKLL | 2481 | Q6ZNJ1 | |
| LNPLGSRSGVRKLLG | 56 | Q96P88 | |
| LRGPIHLSVLRQGKS | 301 | Q9NQV5 | |
| HLRRLNSPIGRDGKL | 481 | P30876 | |
| GLLRRSDRVLPKLLG | 61 | Q8NFA2 | |
| SPLGLALAARERALK | 1351 | Q9Y566 | |
| GLKPLQLLEIKARGR | 186 | Q13705 | |
| KSLGRNRLLPQGLAV | 116 | Q9BYD2 | |
| LSPGLPRLLHLSRGL | 11 | C0HM02 | |
| LHRKGPTSLVLNGIR | 396 | Q8TCW7 | |
| RTLHGLKLGALRKLR | 171 | Q8NB66 | |
| ASRPSKLALGRLGIL | 716 | Q8IVF5 | |
| RGRLPTLLHLGRLAL | 541 | Q9HC29 | |
| PRTGGLAKRLANLIR | 556 | Q969N2 | |
| PLTHLDLRGNRLKLL | 201 | O94991 | |
| DLQRLGGLLSHLRKT | 601 | Q5XPI4 | |
| GGLRLKLPTLGARAR | 1241 | Q9BXM0 | |
| RAPGLLGSRARLPLK | 196 | Q8NBB4 | |
| RRGALIPNGESLLKR | 11 | Q6ICG8 | |
| GLTLLIPYLLGRKRR | 841 | P55017 | |
| SGLLKVAGLLPLLRE | 1741 | Q9NY15 | |
| PREKLTLRLLLGSGA | 1941 | P08922 | |
| ALKKGLIPREQGLRL | 3256 | Q15149 | |
| TFLGHRLLKRLLGPK | 121 | O00337 | |
| KLVSRPRALLHGLRG | 166 | F5GYI3 | |
| RALGSLPSGLAHKLL | 121 | Q5T619 | |
| GLRPSALARLARKLS | 106 | C9JI98 | |
| IKLGRRNGLHLPRET | 146 | P52888 | |
| RRGKRTSPLDLKLGH | 4111 | Q5T4S7 | |
| LLPTKRHLLLGSDNG | 1921 | Q562E7 | |
| PQLQLRGKRAAGLLL | 26 | Q6ZTC4 | |
| QKLASLRLGGAEPRL | 676 | Q8WXH2 | |
| RKHLYLLRGLPGSGK | 41 | Q5TBK1 |